Cargando…
Quinidine effective for the management of ventricular and atrial arrhythmias associated with Brugada syndrome
Autores principales: | Halperin, Laura, Mellor, Greg, Talajic, Mario, Krahn, Andrew, Tadros, Rafik, Laksman, Zachary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050440/ https://www.ncbi.nlm.nih.gov/pubmed/30023269 http://dx.doi.org/10.1016/j.hrcr.2018.01.008 |
Ejemplares similares
-
Quinidine for Brugada syndrome: Panacea or poison?
por: Hai, Jo-Jo, et al.
Publicado: (2016) -
Beneficial Effects of Isoproterenol and Quinidine in the Treatment of Ventricular Fibrillation in Brugada Syndrome
por: Dakkak, Melissa, et al.
Publicado: (2015) -
Exercise Testing With Flecainide Demonstrates Provocable Brugada Syndrome
por: Safabakhsh, Sina, et al.
Publicado: (2021) -
Quinidine: an "Endangered Species" Drug Appropriate for Management of Electrical Storm in Brugada Syndrome
por: Paraskevaidis, Stelios, et al.
Publicado: (2013) -
Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society
por: Sapp, John L., et al.
Publicado: (2020)